Answers are grounded in this paper and cite their sources.
Background: Automated classification of bronchoscopic findings is hindered by severe class imbalance, visual similarity between findings, and scarce expert-annotated data. This study benchmarked convolutional, Transformer, hybrid, and foundation models for multi-label bronchoscopic finding classification. Methods: ResNet-50, EfficientNet-B3, ViT-B/16, Swin-T, and Hybrid-EffSwin (average-pooling fusion of EfficientNet-B3 and Swin-T) were trained on 23 finding categories of the Bronchoscopy Examination Report Dataset (BERD) using identical hyperparameters and patient-level data splits. ConvNeXt-T and two foundation models (DINOv2 ViT-B/14 and BiomedCLIP ViT-B/16) served as additional baselines. Ablations examined fusion strategy, loss function, and decision thresholds. Models were compared using patient-level bootstrap confidence intervals (CIs) and Holm-corrected Wilcoxon tests on patient-level summaries. Results: On the independent test set (316 images, 180 patients), Hybrid-EffSwin achieved the highest macro F1-score (0.376), Matthews correlation coefficient (0.339), and area under the ROC curve (0.803). Across three training seeds, Hybrid-EffSwin ranked first in every run (macro F1 = 0.363 \((±)\) 0.013); its advantage over ResNet-50 and ViT-B/16 was significant in all runs, over EfficientNet-B3 in one of three, and over Swin-T in none (\((Δ)\)F1 = +0.020 to +0.025).Among additional baselines, DINOv2 performed comparably to Hybrid-EffSwin (Hybrid-EffSwin minus DINOv2: \((Δ)\)F1 = +0.013; 95% CI \((-)\)0.025 to 0.052) and achieved the best exact-match accuracy and calibration, whereas ConvNeXt-T was significantly inferior; a late-fusion ensemble of separately trained EfficientNet-B3 and Swin-T performed close to Hybrid-EffSwin. Average-pooling fusion performed at least as well as residual-projection and concatenation fusion, and validation-selected thresholds changed macro F1 only modestly. Conclusions: Hybrid CNN-Transformer, hierarchical Transformer, and self-supervised foundation models formed the strongest tier for multi-label bronchoscopic classification and could not be distinguished on the current test set. Multi-institutional validation is warranted.
No takes yet. Share an insight, caveat, or question.
Ilkay Sibel Kervancı (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: